![N-(3-chloropyridin-2-yl)-N-[(3R)-piperidin-3-yl]-4-(3H-[1,2,3]triazolo[4,5-b]pyridin-3-yl)benzamide in PDB entry 6om0, assembly 1, side view.](https://www.ebi.ac.uk/pdbe/static/entry/6om0_entity_86_side_image-200x200.png "Hetero 83-meric assembly 1 of PDB entry <span class='highlight'>6om0</span> contains 1 copy of <span class='highlight'>N-(3-chloropyridin-2-yl)-N-[(3R)-piperidin-3-yl]-4-(3H-[1,2,3]triazolo[4,5-b]pyridin-3-yl)benzamide</span>. Side view.")
![N-(3-chloropyridin-2-yl)-N-[(3R)-piperidin-3-yl]-4-(3H-[1,2,3]triazolo[4,5-b]pyridin-3-yl)benzamide in PDB entry 6om0, assembly 1, top view.](https://www.ebi.ac.uk/pdbe/static/entry/6om0_entity_86_top_image-200x200.png "Hetero 83-meric assembly 1 of PDB entry <span class='highlight'>6om0</span> contains 1 copy of <span class='highlight'>N-(3-chloropyridin-2-yl)-N-[(3R)-piperidin-3-yl]-4-(3H-[1,2,3]triazolo[4,5-b]pyridin-3-yl)benzamide</span>. Top view.")
Environment details NEW
MVM 5110 bound to chain t
The above 2D and 3D (Mol*) views of ligand interactions use quaternary structure derived from the PDB entry.
Please note:
Please note:
- Some chain IDs in the tooltip are followed by a number in square brackets. This number corresponds to the operation ID (mmCIF ‘oper_expression’) used to transform the chain.
- The structure seen in Mol* (3D view) was protonated using ChimeraX.
- Interactions were calculated using Arpeggio (see details for interaction types).
- The colour scheme used is consistent with Clustal X.